Chicago Tribune
I freelanced for the Chicago Tribune and its affiliate newspapers such as The Naperville Sun for several years. I covered a variety of local stories, including government boards and local elections. Below is a sample of articles I wrote for the Tribune.
Friends hopeful they again will see journalist detained in Iran - 2015
Reporter Jason Rezaian's release from Iran brings comfort to Wheaton friends - 2016
College of DuPage employees call on board to get back to business - 2016
COD moves on probation plan - 2016
I broke into journalism in 2000. My first job was as a government reporter for The Daily Southerner, a small paper in the eastern N.C. town of Tarboro. I was hired away by a mid-sized paper, The Wilson Daily Times (now known as The Wilson Times) to work as that paper's first political reporter. I built that beat from the ground up, developing sources across the state.
I worked in that role for seven years until I moved to the Chicago region for an opportunity outside of journalism. Within two years, I shifted back into journalism and launched a freelance career in 2008. Since then, I have written for multiple media outlets about a variety of topics. In 2015, my focus shifted to the pharmaceutical industry and I have been writing about drug developers, contract manufacturing organizations, and more since that time.
Keown Media Services
WRITER | EDITOR | STORYTELLER
BioBuzz
I began writing about pharma and life sciences companies based in the BioHealth Capital Region and the greater Philadelphia area in 2020. Below is a sample of articles I wrote for BioBuzz and a more complete list of articles I wrote can be found here.
Addimmune Prepares to Go Public, Initiates Phase Ib HIV Trial-- 2023
Why It Pays to Buy Pre-owned Lab Equipment, Especially in This Economy -- 2023
Life Science Cares Philly Takes Aim at Poverty in Philadelphia -- 2021
The Road for Z-SC1’s ULT Freezers in the U.S. Begins in Baltimore- 2020
Philadelphia – A Biopharma Hub on the Move - 2020
Gain Therapeutics and UMSOM Partner to Investigate Small Molecule Drugs - 2020
One-Fourth of Maryland’s Future 20 are Life Science Companies - 2020
BioSpace
Since 2015 I have written thousands of articles about the pharmaceutical industry for BioSpace. I have covered drug approvals, mergers and acquisitions, c-suite transitions, and even scandals and scoundrels within the industry. Below is a sample of articles I wrote for BioSpace.
FDA Approves Third-Ever Drug for ALS - Amylyx's AMX0035 - 2022
AbbVie is Enabling Students Diagnosed with Immunological Diseases to Shine - 2022
HIV Epidemic: 40 Years Later - 2021
Biopharma CEOs on What to Expect at 2021 J.P. Morgan Healthcare Conference - 2021
Sanofi Executives Predict 2021 Will be 'Transformative' Year for Company - 2021
Bayer Continues Eying Potential Partnerships in Cell and Gene Therapy Space- 2021
180 Life Sciences Poised to Break Ground with Anti-TNF Program - 2021
Insys Founder Sentenced to 66 Months for Scheme to Boost Opioid Sales - 2020
Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations - 2020
Genentech Brings Back One of Its Own as Next CEO - 2019
Exclusive: AbbVie Continues Philanthropic Giving With $40 Million to Build a Middle School - 2019
BioSpace Hotbed Report: A Look at the Life Science Industry in the City by the Bay - 2019
Purdue Pharma Files for Bankruptcy as $10-$12 Billion Opioid Settlement Moves Forward - 2019
Notorious 'Pharma Bro' Martin Shkreli Found Guilty, Faces up to 20 Years in Prison -- 2017